Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
[PubMed - indexed for MEDLINE]
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
[PubMed - indexed for MEDLINE]
3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
4.

Amisulpride: a review of its efficacy in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 2000;400:17-22. Review.

PMID:
10823307
[PubMed - indexed for MEDLINE]
5.

Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

Tollefson GD, Andersen SW.

J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. Review.

PMID:
10192404
[PubMed - indexed for MEDLINE]
6.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
7.

Risperidone: how good is the evidence for efficacy?

Mattes JA.

Schizophr Bull. 1997;23(1):155-61. Review.

PMID:
9050121
[PubMed - indexed for MEDLINE]
Free Article
8.

Risperidone: efficacy and safety.

Umbricht D, Kane JM.

Schizophr Bull. 1995;21(4):593-606. Review.

PMID:
8749887
[PubMed - indexed for MEDLINE]
Free Article
9.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
[PubMed - indexed for MEDLINE]
10.

Safety profile of amisulpride in short- and long-term use.

Rein W, Coulouvrat C, Dondey-Nouvel L.

Acta Psychiatr Scand Suppl. 2000;400:23-7. Review.

PMID:
10823308
[PubMed - indexed for MEDLINE]
11.

Risperidone: an analysis of the first three years in general use.

Gutierrez-Esteinou R, Grebb JA.

Int Clin Psychopharmacol. 1997 Sep;12 Suppl 4:S3-10. Review.

PMID:
9352340
[PubMed - indexed for MEDLINE]
12.

The negative component in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 1995;388:11-4. Review.

PMID:
7541597
[PubMed - indexed for MEDLINE]
13.

Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.

De Deyn PP, Katz IR.

Int J Geriatr Psychiatry. 2000 Jul;15 Suppl 1:S14-22. Review. No abstract available.

PMID:
10767745
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia.

Singh D, O'Connor DW.

Clin Interv Aging. 2009;4:351-5. Epub 2009 Sep 1. Review.

PMID:
19750235
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Angioneurotic edema with risperidone: a case report and review of literature.

Soumya RN, Grover S, Dutt A, Gaur N.

Gen Hosp Psychiatry. 2010 Nov-Dec;32(6):646.e1-3. doi: 10.1016/j.genhosppsych.2010.03.005. Epub 2010 Apr 2. Review.

PMID:
21112458
[PubMed - indexed for MEDLINE]
16.

Remission in schizophrenia: critical and systematic review.

AlAqeel B, Margolese HC.

Harv Rev Psychiatry. 2012 Nov-Dec;20(6):281-97. doi: 10.3109/10673229.2012.747804. Review.

PMID:
23216066
[PubMed - indexed for MEDLINE]
17.

Children with schizophrenia: diagnosis, phenomenology, and pharmacotherapy.

Spencer EK, Campbell M.

Schizophr Bull. 1994;20(4):713-25. Review.

PMID:
7701278
[PubMed - indexed for MEDLINE]
Free Article
18.

The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Ulrich S, Wurthmann C, Brosz M, Meyer FP.

Clin Pharmacokinet. 1998 Mar;34(3):227-63. Review.

PMID:
9533984
[PubMed - indexed for MEDLINE]
19.

Relevance of polymorphic drug oxidation in the use of neuroleptics in schizophrenia.

Tang SW.

Prog Clin Biol Res. 1986;214:303-11. Review. No abstract available.

PMID:
2873579
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk